Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Project ALS, a non-profit 501(c)3 leader in the pursuit of treatments and a cure for the neurodegenerative disease ALS, has announced its research...
The ALS Association and Project ALS are pleased to announce that their jointly sponsored pilot program has resulted in this week's announcement by...
Project ALS, a non-profit 501(c)3 organization that funds research toward the first meaningful treatments for amyotrophic lateral sclerosis (ALS),...
Project ALS signals the start of its 5th annual Don't Talk-a-Thon, a digital fundraising campaign in which supporters vow to take at least an hour of ...
Columbia University and Project ALS today announced the Project ALS Therapeutics Core at Columbia, a 3-year, $6.3M initiative toward the first...
Project ALS and Amylyx Pharmaceuticals today announced a collaboration to undertake pre-clinical studies with Amylyx's oral compound AMX0035 to...
The non-profit group Project ALS announced its annual nationwide fundraiser, the Don't Talk-a-Thon, taking place from April 10th through May 21. The...
Brothers Mike and Joey Devlin announced their plans to travel across the U.S. to raise significant research funds for Project ALS in an effort to try ...
Project ALS announced the Team Chris Combs Research Initiative at Project ALS. Team Chris Combs' initial $1M donation will kick-start promising...
Today, Project ALS announced a new research initiative, The Kleiner Family Research Initiative at Project ALS, which will focus intensively on two...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.